伊朗组织相容性抗原（HLA）与多发性硬化症的关联。
Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran.
作者信息
Kalanie H, Kamgooyan M, Sadeghian H, Kalanie A R
机构信息
Department of Neurology, Shohada Hospital, Tajrish, Tehran, Iran.
出版信息
Mult Scler. 2000 Oct;6(5):317-9. doi: 10.1177/135245850000600504.
Human leukocyte antigen (HLA) types were obtained from 79 Iranian patients with multiple sclerosis and compared with 100 controls. The prevalence of HLA-A24 (30.3% versus 18.0%), HLA-DR2 (43.0% versus 28. 0%) and HLA-DR15 (36.7% versus 23.0%) were significantly increased in multiple sclerosis patients compared with controls. However age at onset, and disease status (relapsing - remitting or primary progressive) did not show an association with any particular HLA type. Multiple Sclerosis (2000) 6 317 - 319
从79名伊朗多发性硬化症患者身上获取了人类白细胞抗原（HLA）类型，并与100名对照者进行了比较。与对照组相比，多发性硬化症患者中HLA - A24（30.3%对18.0%）、HLA - DR2（43.0%对28.0%）和HLA - DR15（36.7%对23.0%）的患病率显著升高。然而，发病年龄和疾病状态（复发缓解型或原发进展型）与任何特定的HLA类型均无关联。《多发性硬化症》（2000年）6卷 317 - 319页
Zotero 插件